|
| 35972438 | IDH1/2 wildtype gliomas grade 2 and 3 with molecular glioblastoma-like profile have a distinct course of epilepsy compared to IDH1/2 wildtype glioblastomas. | Neuro Oncol | 2023 |
| 38024241 | Longitudinal characteristics of T2-FLAIR mismatch in IDH-mutant astrocytomas: Relation to grade, histopathology, and overall survival in the GLASS-NL cohort. | Neurooncol Adv | 2023 |
| 37855895 | Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042-26042. | Acta Neuropathol | 2023 |
| 37061716 | Tumor lineage-specific immune response in brain metastatic disease: opportunities for targeted immunotherapy regimen? | Acta Neuropathol Commun | 2023 |
| 37046796 | Microvasculature Features Derived from Hybrid EPI MRI in Non-Enhancing Adult-Type Diffuse Glioma Subtypes. | Cancers (Basel) | 2023 |
| 37441086 | Glioblastoma lacking necrosis or vascular proliferations: Different clinical presentation but similar outcome, regardless of histology or isolated <i>TERT</i> promoter mutation. | Neurooncol Adv | 2023 |
| 36920679 | Medulloblastoma in adults: evaluation of the Dutch society for neuro-oncology treatment protocol. | J Neurooncol | 2023 |
| 36571817 | Mitotic count is prognostic in IDH mutant astrocytoma without homozygous deletion of CDKN2A/B. Results of consensus panel review of EORTC trial 26053 (CATNON) and EORTC trial 22033-26033. | Neuro Oncol | 2023 |
| 36634572 | The value of prognostic and predictive parameters in early-stage lung adenocarcinomas: A comparison between biopsies and resections. | Lung Cancer | 2023 |
| 36494005 | Identification, validation and biological characterisation of novel glioblastoma tumour microenvironment subtypes: implications for precision immunotherapy. | Ann Oncol | 2023 |
| 36454268 | Efficacy and safety of peptide receptor radionuclide therapy with [<sup>177</sup>Lu]Lu-DOTA-TATE in 15 patients with progressive treatment-refractory meningioma. | Eur J Nucl Med Mol Imaging | 2023 |
| 34608482 | The EGFRvIII transcriptome in glioblastoma: A meta-omics analysis. | Neuro Oncol | 2022 |
| 35476433 | A unified 3D map of microscopic architecture and MRI of the human brain. | Sci Adv | 2022 |
| 35731991 | Joint Final Report of EORTC 26951 and RTOG 9402: Phase III Trials With Procarbazine, Lomustine, and Vincristine Chemotherapy for Anaplastic Oligodendroglial Tumors. | J Clin Oncol | 2022 |
| 35563452 | Novel Antibody-Peptide Binding Assay Indicates Presence of Immunoglobulins against EGFR Phospho-Site S1166 in High-Grade Glioma. | Int J Mol Sci | 2022 |
| 36446943 | Author Correction: Failure of human rhombic lip differentiation underlies medulloblastoma formation. | Nature | 2022 |
| 36131014 | Failure of human rhombic lip differentiation underlies medulloblastoma formation. | Nature | 2022 |
| 33606114 | Mapping tumour heterogeneity with pulsed 3D CEST MRI in non-enhancing glioma at 3Â T. | MAGMA | 2022 |
| 35275197 | Temozolomide and Radiotherapy versus Radiotherapy Alone in Patients with Glioblastoma, IDH-wildtype: Post Hoc Analysis of the EORTC Randomized Phase III CATNON Trial. | Clin Cancer Res | 2022 |
| 35294545 | Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC Trial. | Clin Cancer Res | 2022 |
| 33226812 | Identification of Blood-Brain Barrier-Associated Proteins in the Human Brain. | J Proteome Res | 2021 |
| 33879448 | Cross-Species Genomics Reveals Oncogenic Dependencies in ZFTA/C11orf95 Fusion-Positive Supratentorial Ependymomas. | Cancer Discov | 2021 |
| 33741928 | The transcriptional landscape of Shh medulloblastoma. | Nat Commun | 2021 |
| 33740099 | Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations. | Acta Neuropathol | 2021 |
| 33514525 | Detection of Aneuploidy in Cerebrospinal Fluid from Patients with Breast Cancer Can Improve Diagnosis of Leptomeningeal Metastases. | Clin Cancer Res | 2021 |
| 33914057 | Prognostic significance of genome-wide DNA methylation profiles within the randomized, phase 3, EORTC CATNON trial on non-1p/19q deleted anaplastic glioma. | Neuro Oncol | 2021 |
| 34409497 | Subgroup and subtype-specific outcomes in adult medulloblastoma. | Acta Neuropathol | 2021 |
| 34203581 | Differential Expression of <i>BOC</i>, <i>SPOCK2</i>, and <i>GJD3</i> Is Associated with Brain Metastasis of ER-Negative Breast Cancers. | Cancers (Basel) | 2021 |
| 34000245 | Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study. | Lancet Oncol | 2021 |
| 32205200 | DNA-nanorobot-guided thrombin-inducing tumor infarction: raising new potential clinical concerns. | Drug Discov Today | 2020 |
| 31996992 | cIMPACT-NOW update 5: recommended grading criteria and terminologies for IDH-mutant astrocytomas. | Acta Neuropathol | 2020 |
| 31755223 | Medulloblastoma has a global impact on health related quality of life: Findings from an international cohort. | Cancer Med | 2020 |
| 31960518 | Metabolic changes related to the IDH1 mutation in gliomas preserve TCA-cycle activity: An investigation at the protein level. | FASEB J | 2020 |
| 31637414 | Survival of diffuse astrocytic glioma, IDH1/2 wildtype, with molecular features of glioblastoma, WHO grade IV: a confirmation of the cIMPACT-NOW criteria. | Neuro Oncol | 2020 |
| 31743054 | Molecular Evolution of <i>IDH</i> Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 Study. | J Clin Oncol | 2020 |
| 33110452 | Case report: a fatal combination of hemophagocytic lymphohistiocytosis with extensive pulmonary microvascular damage in COVID-19 pneumonia. | J Hematop | 2020 |
| 33096449 | Spinal meningiomas: Treatment outcome and long-term follow-up. | Clin Neurol Neurosurg | 2020 |
| 33383615 | Cerebral Metastasis of Common Cancers. | Cancers (Basel) | 2020 |
| 32766140 | The Association Between the Extent of Glioblastoma Resection and Survival in Light of MGMT Promoter Methylation in 326 Patients With Newly Diagnosed IDH-Wildtype Glioblastoma. | Front Oncol | 2020 |
| 32793885 | Multiomics profiling of paired primary and recurrent glioblastoma patient tissues. | Neurooncol Adv | 2020 |
| 32647861 | Periostin Is Expressed by Pericytes and Is Crucial for Angiogenesis in Glioma. | J Neuropathol Exp Neurol | 2020 |
| 32642695 | Circulating angiogenic cells in glioblastoma: toward defining crucial functional differences in CAC-induced neoplastic versus reactive neovascularization. | Neurooncol Adv | 2020 |
| 32811146 | Phosphorylation Ratio Determination in Fresh-Frozen and Formalin-Fixed Paraffin-Embedded Tissue with Targeted Mass Spectrometry. | J Proteome Res | 2020 |
| 32477929 | Topographical Mapping of 436 Newly Diagnosed IDH Wildtype Glioblastoma With vs. Without MGMT Promoter Methylation. | Front Oncol | 2020 |
| 32307792 | cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and grading. | Brain Pathol | 2020 |
| 30876815 | Elusive Neurotoxicity in T Cell-Boosting Anticancer Therapies. | Trends Immunol | 2019 |
| 33889844 | Differences in spatial distribution between WHO 2016 low-grade glioma molecular subgroups. | Neurooncol Adv | 2019 |
| 34484811 | Immune-Related Circulating miR-125b-5p and miR-99a-5p Reveal a High Recurrence Risk Group of Pancreatic Cancer Patients after Tumor Resection. | Appl Sci (Basel) | 2019 |
| 31664194 | Recurrent noncoding U1Â snRNA mutations drive cryptic splicing in SHH medulloblastoma. | Nature | 2019 |
| 31735293 | TMX2 Is a Crucial Regulator of Cellular Redox State, and Its Dysfunction Causes Severe Brain Developmental Abnormalities. | Am J Hum Genet | 2019 |